Consumers: Don’t impede access to PSE medicines
WASHINGTON — A survey by the Asthma and Allergy Foundation of America (AAFA) has revealed consumer concerns about access to over-the-counter cold/cough and allergy medicines containing pseudoephedrine (PSE). AAFA said Tuesday that the five-state survey of 2,027 users of OTC medicine for nasal allergies, asthma and/or cold, cough or flu, conducted by Harris Poll, shows
